Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.375
+0.180 (8.20%)
Aug 21, 2026, 4:08 PM HKT
Clover Biopharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 267.63 | 401.24 | 735.86 | 1,607 | 2,767 |
Short-Term Investments | - | - | 2.94 | 2.94 | 61.09 |
Trading Asset Securities | 14.62 | 14.78 | 14.17 | 13.93 | 30.91 |
Cash & Short-Term Investments | 282.25 | 416.02 | 752.97 | 1,624 | 2,859 |
Cash Growth | -32.16% | -44.75% | -53.64% | -43.19% | 263.55% |
Accounts Receivable | 0 | 40.99 | 24.11 | - | - |
Other Receivables | 22.92 | 24.21 | 49.6 | - | - |
Receivables | 22.92 | 65.21 | 73.71 | - | - |
Inventory | 9.86 | 11.03 | 696.98 | 2,384 | 768.69 |
Restricted Cash | 3.77 | 11.5 | 13.29 | 16.3 | 6.8 |
Other Current Assets | 17.03 | 159.44 | 362.58 | 365.01 | 1,442 |
Total Current Assets | 335.83 | 663.21 | 1,900 | 4,390 | 5,076 |
Property, Plant & Equipment | 94.47 | 116.18 | 162.06 | 241.74 | 222.4 |
Other Intangible Assets | 27.61 | 33.35 | 39.86 | 35 | 13.83 |
Other Long-Term Assets | - | - | - | 28.04 | 32.93 |
Total Assets | 457.92 | 812.74 | 2,101 | 4,695 | 5,346 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 107.99 | 120.45 | 247.83 | 856.96 | 588.56 |
Accrued Expenses | 36.18 | 42.26 | 70.62 | 88.47 | 96.9 |
Short-Term Debt | - | 73.97 | 308.06 | 294.06 | - |
Current Portion of Leases | 10.61 | 12.18 | 18.54 | 23.57 | 21.48 |
Current Unearned Revenue | 1,573 | 1,612 | 1,578 | 1,555 | 1,424 |
Other Current Liabilities | 23.24 | 46.35 | 54.11 | 10.84 | 17.62 |
Total Current Liabilities | 1,751 | 1,908 | 2,277 | 2,829 | 2,148 |
Long-Term Leases | - | 3.5 | 7.85 | 36.74 | 46.44 |
Long-Term Unearned Revenue | 3.4 | 25.3 | 44.36 | 2,497 | 1,932 |
Other Long-Term Liabilities | 501.2 | 512.58 | 505.05 | - | - |
Total Liabilities | 2,255 | 2,449 | 2,834 | 5,363 | 4,127 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.84 | 0.84 | 0.84 | 0.84 | 0.74 |
Additional Paid-In Capital | 8,670 | 8,654 | 8,621 | 8,562 | 7,972 |
Retained Earnings | -10,749 | -10,544 | -9,640 | -9,502 | -7,050 |
Treasury Stock | -0.02 | -0.03 | -0.03 | -0.04 | -0.05 |
Comprehensive Income & Other | 281 | 252.84 | 285.85 | 270.38 | 296.63 |
Shareholders' Equity | -1,797 | -1,636 | -732.83 | -668.14 | 1,219 |
Total Liabilities & Equity | 457.92 | 812.74 | 2,101 | 4,695 | 5,346 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 10.61 | 89.64 | 334.45 | 354.37 | 67.92 |
Net Cash (Debt) | 271.64 | 326.38 | 418.52 | 1,270 | 2,791 |
Net Cash Growth | -16.77% | -22.02% | -67.04% | -54.51% | - |
Net Cash Per Share | 0.22 | 0.26 | 0.34 | 1.15 | 2.41 |
Filing Date Shares Outstanding | 1,298 | 1,297 | 1,296 | 1,293 | 1,158 |
Total Common Shares Outstanding | 1,298 | 1,297 | 1,296 | 1,293 | 1,158 |
Working Capital | -1,415 | -1,244 | -377.48 | 1,561 | 2,928 |
Book Value Per Share | -1.38 | -1.26 | -0.57 | -0.52 | 1.05 |
Tangible Book Value | -1,825 | -1,670 | -772.69 | -703.14 | 1,205 |
Tangible Book Value Per Share | -1.41 | -1.29 | -0.60 | -0.54 | 1.04 |
Buildings | 29.8 | 29.8 | 29.8 | 29.75 | 29.75 |
Machinery | 157.87 | 157.94 | 147.25 | 128.37 | 101.65 |
Construction In Progress | 14.01 | 14.01 | 25.28 | 44.08 | 32.15 |
Leasehold Improvements | 24.17 | 24.17 | 35.79 | 31.6 | 11.38 |